Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Peng

Showing results (671-680 of 780) with videos related to

Pageof 78
Sort By:
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|April 16, 2026
[Study on the status of media exposure to tuberculosis prevention information and its impact on health beliefs and preventive behaviors among lower-grade university students in Guangzhou City]Y T Xu, J Y Yang, Y J Hu, et al.
Alimentary Pharmacology & Therapeutics|June 23, 2015
Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population-based case-crossover studyC-L Tseng, Y-T Chen, C-J Huang, et al.
Occupational and Environmental Medicine|October 20, 2005
A prospective cohort study among new Chinese coal miners: the early pattern of lung function changeM-L Wang, Z-E Wu, Q-G Du, et al.
Cell Death & Disease|June 3, 2016
TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK-STAT signaling pathwayX Zhu, C Xie, Y-M Li, et al.
Yi Chuan Xue Bao = Acta Genetica Sinica|January 1, 1989
[Dermatoglyphics parameters and cluster analysis of seven minority nationalities]H G Zhang, R C Shen, Y B Su, et al.
Cell Death & Disease|June 12, 2025
Correction: TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2. 2. 15 cells by activating the JAK-STAT signaling pathwayX Zhu, C Xie, Y -M Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 1, 2024
[Clinical characteristics of myeloid tumors combined with the proliferation of large granular lymphocytes]C X Du, G P Xiang, L Peng, et al.
Clinical and Translational Science|January 27, 2021
First-in-human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-101, a dual CD28/ICOS antagonist, in healthy adult subjectsJing Yang, Jason D Lickliter, Jan L Hillson, et al.
Cancer Research|October 4, 2000
Early resistance to therapy during induction in childhood acute lymphoblastic leukemiaM J Brisco, P J Sykes, G Dolman, et al.
Zhonghua Yi Xue Za Zhi|January 24, 2019
[Effect of cyclophosphamide on ovarian function in patients with systemic lupus erythematosus in childbearing age]X Liu, L L Zhang, W Zhao, et al.
Pageof 78

Showing results (671-680 of 780) with videos related to

Sort By:
Pageof 78
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|April 16, 2026
[Study on the status of media exposure to tuberculosis prevention information and its impact on health beliefs and preventive behaviors among lower-grade university students in Guangzhou City]Y T Xu, J Y Yang, Y J Hu, et al.
Alimentary Pharmacology & Therapeutics|June 23, 2015
Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population-based case-crossover studyC-L Tseng, Y-T Chen, C-J Huang, et al.
Occupational and Environmental Medicine|October 20, 2005
A prospective cohort study among new Chinese coal miners: the early pattern of lung function changeM-L Wang, Z-E Wu, Q-G Du, et al.
Cell Death & Disease|June 3, 2016
TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK-STAT signaling pathwayX Zhu, C Xie, Y-M Li, et al.
Yi Chuan Xue Bao = Acta Genetica Sinica|January 1, 1989
[Dermatoglyphics parameters and cluster analysis of seven minority nationalities]H G Zhang, R C Shen, Y B Su, et al.
Cell Death & Disease|June 12, 2025
Correction: TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2. 2. 15 cells by activating the JAK-STAT signaling pathwayX Zhu, C Xie, Y -M Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 1, 2024
[Clinical characteristics of myeloid tumors combined with the proliferation of large granular lymphocytes]C X Du, G P Xiang, L Peng, et al.
Clinical and Translational Science|January 27, 2021
First-in-human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-101, a dual CD28/ICOS antagonist, in healthy adult subjectsJing Yang, Jason D Lickliter, Jan L Hillson, et al.
Cancer Research|October 4, 2000
Early resistance to therapy during induction in childhood acute lymphoblastic leukemiaM J Brisco, P J Sykes, G Dolman, et al.
Zhonghua Yi Xue Za Zhi|January 24, 2019
[Effect of cyclophosphamide on ovarian function in patients with systemic lupus erythematosus in childbearing age]X Liu, L L Zhang, W Zhao, et al.
Pageof 78